thyroxine has been researched along with Atherogenesis in 50 studies
Thyroxine: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
thyroxine : An iodothyronine compound having iodo substituents at the 3-, 3'-, 5- and 5'-positions.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The aim of this study was to investigate the concentration of plasma soluble intercellular adhesion molecule-1 and adiponectin in relation to insulin sensitivity in patients with subclinical hypothyroidism and to estimate if L-thyroxine treatment had an influence on these parameters." | 9.15 | Insulin sensitivity, plasma adiponectin and sICAM-1 concentrations in patients with subclinical hypothyroidism: response to levothyroxine therapy. ( Borawski, J; Budlewski, T; Górska, M; Kowalska, I; Nikołajuk, A; Otziomek, E; Strączkowski, M, 2011) |
| " Since thyroid hormones may mediate the association between ARG derivatives and atherosclerosis, this study investigated whether asymmetric and symmetric dimethylarginines (ADMA and SDMA, respectively) as well as homoarginine (hARG) are associated with parameters of thyroid function in the general population." | 7.83 | L-Arginine Derivatives Are Associated with the Hyperthyroid State in the General Population. ( Atzler, D; Bahls, M; Böger, RH; Dörr, M; Felix, SB; Friedrich, N; Ittermann, T; Schwedhelm, E; Völzke, H, 2016) |
| "To investigate the effect of levothyroxine (L-T4) treatment on early markers of atherosclerotic disease in children with mild idiopathic subclinical hypothyroidism (SH)." | 7.83 | Effects of L-thyroxine treatment on early markers of atherosclerotic disease in children with subclinical hypothyroidism. ( Alfano, S; Capalbo, D; Cerbone, M; Cittadini, A; De Luca, F; Mattace Raso, G; Oliviero, U; Salerno, M; Wasniewska, M, 2016) |
| " We aimed to explore the changes in atherosclerotic risk factors and insulin sensitivity before and after levothyroxine replacement therapy in women with primary hypothyroidism and compare with that of healthy controls." | 7.80 | Effects of levothyroxine treatment on insulin sensitivity, endothelial function and risk factors of atherosclerosis in hypothyroid women. ( Akalın, NS; Akpınar, IN; Deyneli, O; Gözü, H; Meriçliler, OS; Yıldız, ME, 2014) |
| " We hypothesized that L-thyroxine replacement therapy might be able to reverse the process associated with increase in CIMT in patients with primary hypothyroidism." | 7.75 | Effects of L-thyroxine replacement therapy on carotid intima-media thickness in patients with primary hypothyroidism. ( Aral, Y; Cakal, B; Cakal, E; Demirbas, B; Ozkaya, M; Serter, R; Turgut, AT, 2009) |
| "Hypothyroidism is a common endocrine disorder and requires lifelong treatment." | 5.91 | Impact of Levothyroxine on Lipid Profile in Patients with Hypothyroidism. ( Ara, S; Islam, MN; Moni, SY; Rahman, FB; Sultana, Z; Zubery, MH, 2023) |
| "Subclinical hypothyroidism (SHypo) has been associated with atherosclerosis, but no conclusive clinical trials assessing the levothyroxine impact on carotid atherosclerosis exist." | 5.27 | Impact of Thyroid Hormone Therapy on Atherosclerosis in the Elderly With Subclinical Hypothyroidism: A Randomized Trial. ( Adam, L; Bauer, DC; Blum, MR; Collet, TH; da Costa, BR; Depairon, M; Dopheide, J; Feller, M; Gencer, B; Gussekloo, J; Kearney, P; Moutzouri, E; Rodondi, N; Stott, DJ; Sykiotis, GP; Westendorp, R, 2018) |
| " The aim of this study was to investigate the concentration of plasma soluble intercellular adhesion molecule-1 and adiponectin in relation to insulin sensitivity in patients with subclinical hypothyroidism and to estimate if L-thyroxine treatment had an influence on these parameters." | 5.15 | Insulin sensitivity, plasma adiponectin and sICAM-1 concentrations in patients with subclinical hypothyroidism: response to levothyroxine therapy. ( Borawski, J; Budlewski, T; Górska, M; Kowalska, I; Nikołajuk, A; Otziomek, E; Strączkowski, M, 2011) |
| "Many studies have found clinical and metabolic alterations in subclinical hypothyroidism, however, there are disagreements about the benefits of levothyroxine therapy." | 5.13 | Treatment of subclinical hypothyroidism reduces atherogenic lipid levels in a placebo-controlled double-blind clinical trial. ( Almeida, CP; Buescu, A; Costa, AJ; Ferreira, MM; Melo, BA; Reis, FA; Reuters, VS; Teixeira, PF; Vaisman, M, 2008) |
| "We expanded the data on cIMT in young women with T1DM and showed that thyroid autoimmunity, and in particular the duration of exposure to anti-thyroid antibodies, despite adequate levothyroxine substitution, is associated with subclinical atherosclerosis in young women with T1DM." | 4.12 | [Is thyroid autoimmunity associated with subclinical atherosclerosis in young women with type 1 diabetes mellitus?] ( Czupryniak, L; Franek, E; Mrozikiewicz-Rakowska, B; Zieliński, J; Łukawska-Tatarczuk, MM, 2022) |
| "In this study, we aimed to evaluate serum irisin and apelin levels in patients with subclinical hypothyroidism (SCH) when they were subclinical hypothyroid and become euthyroid after levothyroxine therapy and association of these adipokines with markers of atherosclerosis such as serum homocysteine levels and carotid intima-media thickness (IMT)." | 3.91 | Serum irisin and apelin levels and markers of atherosclerosis in patients with subclinical hypothyroidism. ( Colak, A; Demirpence, M; Ekinci, F; Günaslan, A; Turkon, H; Yasar, E; Yasar, HY; Yurdakul, L; Zeytinli, M, 2019) |
| "Free thyroxine levels in middle-aged and elderly subjects were positively associated with atherosclerosis throughout the whole disease spectrum, independent of cardiovascular risk factors." | 3.85 | Thyroid Function and the Risk of Atherosclerotic Cardiovascular Morbidity and Mortality: The Rotterdam Study. ( Bano, A; Chaker, L; Franco, OH; Ikram, MA; Kavousi, M; Mattace-Raso, FUS; Peeters, RP; van der Lugt, A, 2017) |
| "Concentrations of thyroid stimulating hormone (TSH), free thyroxine (FT4), triiodothyronine (T3) and thyroid peroxidase antibody (TPOAb) were quantified in 12 785 black and white participants of the ongoing community-based prospective Atherosclerosis Risk in Communities study." | 3.85 | Thyroid function, reduced kidney function and incident chronic kidney disease in a community-based population: the Atherosclerosis Risk in Communities study. ( Coresh, J; Daya, N; Grams, ME; Köttgen, A; Schultheiss, UT; Selvin, E; Seufert, J; Steffes, M, 2017) |
| " Since thyroid hormones may mediate the association between ARG derivatives and atherosclerosis, this study investigated whether asymmetric and symmetric dimethylarginines (ADMA and SDMA, respectively) as well as homoarginine (hARG) are associated with parameters of thyroid function in the general population." | 3.83 | L-Arginine Derivatives Are Associated with the Hyperthyroid State in the General Population. ( Atzler, D; Bahls, M; Böger, RH; Dörr, M; Felix, SB; Friedrich, N; Ittermann, T; Schwedhelm, E; Völzke, H, 2016) |
| "To investigate the effect of levothyroxine (L-T4) treatment on early markers of atherosclerotic disease in children with mild idiopathic subclinical hypothyroidism (SH)." | 3.83 | Effects of L-thyroxine treatment on early markers of atherosclerotic disease in children with subclinical hypothyroidism. ( Alfano, S; Capalbo, D; Cerbone, M; Cittadini, A; De Luca, F; Mattace Raso, G; Oliviero, U; Salerno, M; Wasniewska, M, 2016) |
| " We aimed to explore the changes in atherosclerotic risk factors and insulin sensitivity before and after levothyroxine replacement therapy in women with primary hypothyroidism and compare with that of healthy controls." | 3.80 | Effects of levothyroxine treatment on insulin sensitivity, endothelial function and risk factors of atherosclerosis in hypothyroid women. ( Akalın, NS; Akpınar, IN; Deyneli, O; Gözü, H; Meriçliler, OS; Yıldız, ME, 2014) |
| "Serum total bilirubin, thyrotropin and free thyroxine (free T4), transaminases, insulin sensitivity (homeostasis model assessment), and lipids were measured in 74 T2DM and 82 nondiabetic subjects with thyrotropin and free T4 levels within the euthyroid range." | 3.79 | Low-normal free thyroxine confers decreased serum bilirubin in type 2 diabetes mellitus. ( Bakker, SJ; Deetman, PE; Dullaart, RP; Kwakernaak, AJ, 2013) |
| " We hypothesized that L-thyroxine replacement therapy might be able to reverse the process associated with increase in CIMT in patients with primary hypothyroidism." | 3.75 | Effects of L-thyroxine replacement therapy on carotid intima-media thickness in patients with primary hypothyroidism. ( Aral, Y; Cakal, B; Cakal, E; Demirbas, B; Ozkaya, M; Serter, R; Turgut, AT, 2009) |
| "Instability of atherosclerotic plaque in hypothyroidism could cause excessive activity of the elements of innate immunity, which are characterized by the significant presence of macrophages in atherosclerotic plaques, increased nuclear factor kappa B (NFkB) expression, and elevated levels of tumor necrosis factor α (TNF-α) and matrix metalloproteinase (MMP) 9, with reduced interstitial collagen; all of them together creates inflammation milieu, resulting in plaque rupture." | 2.82 | Hypothyroidism and Risk of Cardiovascular Disease. ( Gluvic, ZM; Isenovic, ER; Obradovic, MM; Rizzo, M; Sudar-Milovanovic, EM; Zafirovic, SS, 2022) |
| "Subclinical hypothyroidism is also associated with the risk of progression to overt hypothyroidism and with the risk of neuropsychiatric effects." | 2.44 | [Subclinical hypothyroidism]. ( Krysiak, R; Marek, B; Okopień, B, 2008) |
| "Sub-clinical hypothyroidism is defined by elevated serum thyroid-stimulating hormone level in the face of normal free thyroid hormone values." | 2.43 | [Cardiovascular remodelling in patients with sub-clinical hypothyroidism]. ( Antonelli, A; Franzoni, F; Galetta, F; Rossi, M; Santoro, G, 2006) |
| "Hypothyroidism is a common endocrine disorder and requires lifelong treatment." | 1.91 | Impact of Levothyroxine on Lipid Profile in Patients with Hypothyroidism. ( Ara, S; Islam, MN; Moni, SY; Rahman, FB; Sultana, Z; Zubery, MH, 2023) |
| "Hypothyroidism was subsequently diagnosed." | 1.62 | Acute Hepatopathy in a Dog Secondary to Hypothyroidism-Induced Atherosclerotic Infarction and Necrosis. ( Bolton, TA, 2021) |
| "Primary hypothyroidism can affect lipid metabolism, cardiovascular (CV) function, and overall patients' quality of life (QoL)." | 1.51 | Serum nitric oxide levels correlate with quality of life questionnaires scores of hypothyroid females. ( Gluvic, ZM; Isenovic, ER; Jevremovic, DP; Obradovic, MM; Radenkovic, SP; Samardzic, VS; Sudar-Milovanovic, EM, 2019) |
| "Clinical hypothyroidism was prevalent (>20% of individuals studied) and was associated with cerebrovascular disease but not Alzheimer's disease-type neuropathology." | 1.48 | Treated hypothyroidism is associated with cerebrovascular disease but not Alzheimer's disease pathology in older adults. ( Brenowitz, WD; Han, F; Kukull, WA; Nelson, PT, 2018) |
| "These findings suggest that elevated cholesterol concentrations in the blood, especially against the background of suppressed thyroid function, can directly induce considerable damage to cardiomyocytes, intramural vessels, and erythrocytes without the development of myocardial ischemia and in the absence of atherosclerotic plaques." | 1.39 | Structural changes in the myocardium and serum lipid spectrum in experimental hypercholesterolemia and hypothyroidism. ( Klinnikova, MG; Lushnikova, EL; Molodykh, OP; Nepomnyashchikh, LM; Nepomnyashchikh, RD; Pichigin, VI; Polyakov, LP; Poteryaeva, ON; Russkikh, GS, 2013) |
| "Seventy subjects with Type 2 diabetes mellitus (T2DM), 37 subjects with impaired fasting glucose (IFG) and 31 subjects with normal fasting glucose (NFG) (revised NCEP-ATPIII criteria) participated in a cross-sectional study." | 1.39 | Low normal free T4 confers decreased high-density lipoprotein antioxidative functionality in the context of hyperglycaemia. ( Annema, W; de Boer, JF; Dullaart, RP; Kwakernaak, AJ; Tietge, UJ; Triolo, M, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (28.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (14.00) | 29.6817 |
| 2010's | 25 (50.00) | 24.3611 |
| 2020's | 4 (8.00) | 2.80 |
| Authors | Studies |
|---|---|
| Łukawska-Tatarczuk, MM | 1 |
| Zieliński, J | 1 |
| Franek, E | 1 |
| Czupryniak, L | 1 |
| Mrozikiewicz-Rakowska, B | 1 |
| Gluvic, ZM | 2 |
| Zafirovic, SS | 1 |
| Obradovic, MM | 2 |
| Sudar-Milovanovic, EM | 2 |
| Rizzo, M | 1 |
| Isenovic, ER | 2 |
| Rahman, FB | 1 |
| Zubery, MH | 1 |
| Moni, SY | 1 |
| Ara, S | 1 |
| Sultana, Z | 1 |
| Islam, MN | 1 |
| Samardzic, VS | 1 |
| Jevremovic, DP | 1 |
| Radenkovic, SP | 1 |
| Bolton, TA | 1 |
| Bano, A | 1 |
| Chaker, L | 1 |
| Mattace-Raso, FUS | 1 |
| van der Lugt, A | 1 |
| Ikram, MA | 1 |
| Franco, OH | 1 |
| Peeters, RP | 1 |
| Kavousi, M | 1 |
| Brenowitz, WD | 1 |
| Han, F | 1 |
| Kukull, WA | 1 |
| Nelson, PT | 1 |
| Anderson, JL | 1 |
| Zhao, JV | 1 |
| Schooling, CM | 1 |
| Ning, Y | 1 |
| Zhang, M | 1 |
| DU, YH | 1 |
| Zhang, HN | 1 |
| Li, LY | 1 |
| Qin, YW | 1 |
| Wen, WW | 1 |
| Zhao, QM | 1 |
| Blum, MR | 1 |
| Gencer, B | 1 |
| Adam, L | 1 |
| Feller, M | 1 |
| Collet, TH | 1 |
| da Costa, BR | 1 |
| Moutzouri, E | 1 |
| Dopheide, J | 1 |
| Depairon, M | 1 |
| Sykiotis, GP | 1 |
| Kearney, P | 1 |
| Gussekloo, J | 1 |
| Westendorp, R | 1 |
| Stott, DJ | 1 |
| Bauer, DC | 1 |
| Rodondi, N | 1 |
| Dietlein, M | 1 |
| Drzezga, A | 1 |
| Yasar, HY | 1 |
| Demirpence, M | 1 |
| Colak, A | 1 |
| Yurdakul, L | 1 |
| Zeytinli, M | 1 |
| Turkon, H | 1 |
| Ekinci, F | 1 |
| Günaslan, A | 1 |
| Yasar, E | 1 |
| Deetman, PE | 1 |
| Kwakernaak, AJ | 2 |
| Bakker, SJ | 1 |
| Dullaart, RP | 3 |
| Nepomnyashchikh, LM | 1 |
| Lushnikova, EL | 1 |
| Polyakov, LP | 1 |
| Molodykh, OP | 1 |
| Klinnikova, MG | 1 |
| Russkikh, GS | 1 |
| Poteryaeva, ON | 1 |
| Nepomnyashchikh, RD | 1 |
| Pichigin, VI | 1 |
| Delitala, AP | 1 |
| Orrù, M | 1 |
| Filigheddu, F | 1 |
| Pilia, MG | 1 |
| Delitala, G | 1 |
| Ganau, A | 1 |
| Saba, PS | 1 |
| Decandia, F | 1 |
| Scuteri, A | 1 |
| Marongiu, M | 1 |
| Lakatta, EG | 1 |
| Strait, J | 1 |
| Cucca, F | 1 |
| Deyneli, O | 1 |
| Akpınar, IN | 1 |
| Meriçliler, OS | 1 |
| Gözü, H | 1 |
| Yıldız, ME | 1 |
| Akalın, NS | 1 |
| Zhang, Y | 2 |
| Wang, Q | 1 |
| Li, Q | 1 |
| Lu, P | 1 |
| Zha, K | 1 |
| Zuo, C | 1 |
| Wang, A | 1 |
| Zhang, B | 1 |
| Wang, B | 1 |
| Wang, Y | 1 |
| Zhao, J | 1 |
| Gao, L | 1 |
| Xu, C | 1 |
| Ittermann, T | 1 |
| Bahls, M | 1 |
| Atzler, D | 1 |
| Friedrich, N | 1 |
| Schwedhelm, E | 1 |
| Böger, RH | 1 |
| Felix, SB | 1 |
| Völzke, H | 1 |
| Dörr, M | 1 |
| Cerbone, M | 3 |
| Capalbo, D | 3 |
| Wasniewska, M | 1 |
| Alfano, S | 1 |
| Mattace Raso, G | 1 |
| Oliviero, U | 2 |
| Cittadini, A | 2 |
| De Luca, F | 2 |
| Salerno, M | 3 |
| Schultheiss, UT | 1 |
| Daya, N | 1 |
| Grams, ME | 1 |
| Seufert, J | 1 |
| Steffes, M | 1 |
| Coresh, J | 1 |
| Selvin, E | 1 |
| Köttgen, A | 1 |
| Krysiak, R | 1 |
| Marek, B | 1 |
| Okopień, B | 1 |
| Cakal, E | 1 |
| Turgut, AT | 1 |
| Demirbas, B | 1 |
| Ozkaya, M | 1 |
| Cakal, B | 1 |
| Serter, R | 1 |
| Aral, Y | 1 |
| Parmar, HS | 1 |
| Kar, A | 1 |
| Bosso, G | 1 |
| Valvano, A | 1 |
| Apuzzi, V | 1 |
| Calabrese, F | 1 |
| Lettiero, T | 1 |
| Kowalska, I | 1 |
| Borawski, J | 1 |
| Nikołajuk, A | 1 |
| Budlewski, T | 1 |
| Otziomek, E | 1 |
| Górska, M | 1 |
| Strączkowski, M | 1 |
| Alibaz Oner, F | 1 |
| Yurdakul, S | 1 |
| Oner, E | 1 |
| Kubat Uzum, A | 1 |
| Erguney, M | 1 |
| Mugii, S | 1 |
| Hanada, H | 1 |
| Okubo, M | 1 |
| Masuda, D | 1 |
| Takeoka, K | 1 |
| Hidaka, Y | 1 |
| Ohama, T | 1 |
| Matsuyama, A | 1 |
| Nakagawa-Toyama, Y | 1 |
| Nishida, M | 1 |
| Ishigami, M | 1 |
| Komuro, I | 1 |
| Yamashita, S | 1 |
| Kim, ES | 1 |
| Shin, JA | 1 |
| Shin, JY | 1 |
| Lim, DJ | 1 |
| Moon, SD | 1 |
| Son, HY | 1 |
| Han, JH | 1 |
| Triolo, M | 1 |
| de Boer, JF | 1 |
| Annema, W | 1 |
| Tietge, UJ | 1 |
| CUTHBERTSON, WF | 1 |
| ELCOATE, PV | 1 |
| IRELAND, DM | 1 |
| MILLS, DC | 1 |
| SHEARLEY, P | 1 |
| DAVIS, OF | 1 |
| BECK, C | 1 |
| BERGAL, M | 1 |
| SLOAN, N | 1 |
| LEVINE, AJ | 1 |
| DUFAULT, C | 2 |
| TREMBLAY, G | 2 |
| NOWACZYNSKI, W | 2 |
| GENEST, J | 2 |
| FELT, V | 1 |
| ROEHLING, S | 1 |
| VOHNOUT, S | 1 |
| HLADOVEC, J | 1 |
| ROMERO, RL | 1 |
| RODRIGUEZ, R | 1 |
| FERRARA, F | 1 |
| MALJAR, L | 1 |
| CACCIATORE, J | 1 |
| VELARDE, HV | 1 |
| LOEPER, J | 2 |
| KRITCHEVSKY, D | 1 |
| SOULAIRAC, A | 1 |
| BEROUTI, R | 1 |
| CAHN, J | 1 |
| AYMARD, N | 1 |
| FISHER, ER | 1 |
| SIMONIN, R | 1 |
| FRUCTUS, X | 1 |
| GEROLAMI AUDRIC, D | 1 |
| BAINBOROUGH, AR | 1 |
| McMILLAN, GC | 1 |
| Liou, YM | 1 |
| Chang, LY | 1 |
| Liaw, JM | 1 |
| Jiang, MJ | 1 |
| Rossi, M | 1 |
| Galetta, F | 1 |
| Franzoni, F | 1 |
| Antonelli, A | 1 |
| Santoro, G | 1 |
| de Vries, R | 1 |
| Roozendaal, C | 1 |
| Kobold, AC | 1 |
| Sluiter, WJ | 1 |
| Teixeira, PF | 1 |
| Reuters, VS | 1 |
| Ferreira, MM | 1 |
| Almeida, CP | 1 |
| Reis, FA | 1 |
| Melo, BA | 1 |
| Buescu, A | 1 |
| Costa, AJ | 1 |
| Vaisman, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Hyperthyroidism and Its Treatment in Graves' Disease to Early Marker of Atherosclerosis: Review on the Pathway of Insulin Resistance, Lipid, Inflammation, and Endothelial Dysfunction to Pulse Wave Velocity and Carotid Intima-Media Thickness[NCT05118542] | Phase 3 | 36 participants (Actual) | Interventional | 2019-01-01 | Completed | ||
| Impact of Thyroid Hormone Replacement on Progression of Atherosclerosis : a Randomized Placebo-Controlled Trial in Older Adults With Subclinical Hypothyroidism.[NCT02832934] | Phase 4 | 184 participants (Actual) | Interventional | 2016-06-30 | Completed | ||
| Effect of Levothyroxine on Serum Adiponectin, Insulin Resistance and Cardiovascular Risk in Patients With Hypothyroidism[NCT02467244] | 120 participants (Actual) | Observational | 2017-02-01 | Completed | |||
| Effects of Levothyroxine on Endothelial Function of Patients With Subclinical Hypothyroidism[NCT02090907] | Phase 2/Phase 3 | 50 participants (Actual) | Interventional | 2013-05-31 | Completed | ||
| Effects of Dapagliflozin on Hyperlipidemia, Glycemic Control and Insulin Resistance in Type 2 Diabetic Patients (DAPHNIS Study)[NCT02577159] | Phase 4 | 50 participants (Anticipated) | Interventional | 2015-07-01 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for thyroxine and Atherogenesis
| Article | Year |
|---|---|
Hypothyroidism and Risk of Cardiovascular Disease.
Topics: Aged; Atherosclerosis; Cardiovascular Diseases; Female; Humans; Hypothyroidism; Plaque, Atherosclero | 2022 |
Subclinical hypothyroidism in childhood - current knowledge and open issues.
Topics: Anticonvulsants; Antiviral Agents; Asymptomatic Diseases; Atherosclerosis; Bone Diseases, Metabolic; | 2016 |
[Subclinical hypothyroidism].
Topics: Atherosclerosis; Cardiovascular Diseases; Comorbidity; Disease Progression; Humans; Hypothyroidism; | 2008 |
[Cardiovascular remodelling in patients with sub-clinical hypothyroidism].
Topics: Atherosclerosis; Carotid Arteries; Humans; Hypothyroidism; Risk Factors; Thyroxine; Ultrasonography; | 2006 |
5 trials available for thyroxine and Atherogenesis
| Article | Year |
|---|---|
Impact of Thyroid Hormone Therapy on Atherosclerosis in the Elderly With Subclinical Hypothyroidism: A Randomized Trial.
Topics: Aged; Aged, 80 and over; Asymptomatic Diseases; Atherosclerosis; Double-Blind Method; Female; Hormon | 2018 |
Association between Hyperhomocysteinemia and Thyroid Hormones in Euthyroid Diabetic Subjects.
Topics: Adult; Aged; Atherosclerosis; Cross-Sectional Studies; Diabetes Complications; Female; Humans; Hyper | 2015 |
Insulin sensitivity, plasma adiponectin and sICAM-1 concentrations in patients with subclinical hypothyroidism: response to levothyroxine therapy.
Topics: Adiponectin; Adult; Aged; Atherosclerosis; Biomarkers; Blood Glucose; Case-Control Studies; Choleste | 2011 |
Evaluation of the effect of L-thyroxin therapy on endothelial functions in patients with subclinical hypothyroidism.
Topics: Adult; Atherosclerosis; Blood Flow Velocity; Brachial Artery; Endothelium, Vascular; Female; Hormone | 2011 |
Treatment of subclinical hypothyroidism reduces atherogenic lipid levels in a placebo-controlled double-blind clinical trial.
Topics: Atherosclerosis; Double-Blind Method; Female; Humans; Hypothyroidism; Lipid Metabolism; Male; Menopa | 2008 |
41 other studies available for thyroxine and Atherogenesis
| Article | Year |
|---|---|
[Is thyroid autoimmunity associated with subclinical atherosclerosis in young women with type 1 diabetes mellitus?]
Topics: Atherosclerosis; Autoimmunity; Carotid Intima-Media Thickness; Diabetes Mellitus, Type 1; Female; Ha | 2022 |
Impact of Levothyroxine on Lipid Profile in Patients with Hypothyroidism.
Topics: Atherosclerosis; Bangladesh; Cholesterol, LDL; Cross-Sectional Studies; Female; Humans; Hypothyroidi | 2023 |
Serum nitric oxide levels correlate with quality of life questionnaires scores of hypothyroid females.
Topics: Adult; Atherosclerosis; Biomarkers; Blood Pressure; Body Mass Index; C-Reactive Protein; Female; Gly | 2019 |
Acute Hepatopathy in a Dog Secondary to Hypothyroidism-Induced Atherosclerotic Infarction and Necrosis.
Topics: Animals; Atherosclerosis; Dog Diseases; Dogs; Hepatic Infarction; Hypothyroidism; Liver Diseases; Ma | 2021 |
Thyroid Function and the Risk of Atherosclerotic Cardiovascular Morbidity and Mortality: The Rotterdam Study.
Topics: Aged; Atherosclerosis; Female; Humans; Male; Middle Aged; Thyroid Gland; Thyroxine | 2017 |
Treated hypothyroidism is associated with cerebrovascular disease but not Alzheimer's disease pathology in older adults.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Atherosclerosis; Cerebrovascular Disorders; Drug Combina | 2018 |
Circulating Thyroxine: A Major New Risk Marker for Atherosclerosis?
Topics: Atherosclerosis; Atrial Fibrillation; Humans; Thyroxine | 2017 |
Letter by Zhao and Schooling Regarding Article, "Thyroid Function and the Risk of Atherosclerotic Cardiovascular Morbidity and Mortality: The Rotterdam Study".
Topics: Atherosclerosis; Humans; Thyroxine | 2018 |
[Effects of thyroid hormone on macrophage dysfunction induced by oxidized low-density lipoprotein].
Topics: Animals; Atherosclerosis; Chemokine CCL2; Foam Cells; Focal Adhesion Kinase 1; Interleukin-1beta; Li | 2018 |
Topics: Atherosclerosis; Cognition Disorders; Drug Utilization; Heart Diseases; Humans; Hypothyroidism; Rena | 2018 |
Serum irisin and apelin levels and markers of atherosclerosis in patients with subclinical hypothyroidism.
Topics: Adult; Aged; Apelin; Atherosclerosis; Biomarkers; Carotid Intima-Media Thickness; Case-Control Studi | 2019 |
Low-normal free thyroxine confers decreased serum bilirubin in type 2 diabetes mellitus.
Topics: Aged; Antioxidants; Aspartate Aminotransferases; Atherosclerosis; Bilirubin; Cholesterol; Diabetes M | 2013 |
Structural changes in the myocardium and serum lipid spectrum in experimental hypercholesterolemia and hypothyroidism.
Topics: Animals; Atherosclerosis; Body Weight; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; | 2013 |
Serum free thyroxine levels are positively associated with arterial stiffness in the SardiNIA study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aorta; Atherosclerosis; Body Mass Index; Cardiovascular | 2015 |
Effects of levothyroxine treatment on insulin sensitivity, endothelial function and risk factors of atherosclerosis in hypothyroid women.
Topics: Adolescent; Adult; Atherosclerosis; Endothelium, Vascular; Female; Glucose Clamp Technique; Humans; | 2014 |
LDL in patients with subclinical hypothyroidism shows increased lipid peroxidation.
Topics: Asymptomatic Diseases; Atherosclerosis; Body Mass Index; Carotid Intima-Media Thickness; Female; Hum | 2015 |
L-Arginine Derivatives Are Associated with the Hyperthyroid State in the General Population.
Topics: Adult; Aged; Aged, 80 and over; Arginine; Atherosclerosis; Cross-Sectional Studies; Female; Germany; | 2016 |
Effects of L-thyroxine treatment on early markers of atherosclerotic disease in children with subclinical hypothyroidism.
Topics: Adolescent; Atherosclerosis; Biomarkers; Blood Pressure; Carotid Intima-Media Thickness; Case-Contro | 2016 |
Thyroid function, reduced kidney function and incident chronic kidney disease in a community-based population: the Atherosclerosis Risk in Communities study.
Topics: Atherosclerosis; Biomarkers; Cross-Sectional Studies; Female; Glomerular Filtration Rate; Humans; Hy | 2017 |
Effects of L-thyroxine replacement therapy on carotid intima-media thickness in patients with primary hypothyroidism.
Topics: Adult; Atherosclerosis; Carotid Arteries; Cholesterol, HDL; Cholesterol, LDL; Female; Hormone Replac | 2009 |
Possible amelioration of atherogenic diet induced dyslipidemia, hypothyroidism and hyperglycemia by the peel extracts of Mangifera indica, Cucumis melo and Citrullus vulgaris fruits in rats.
Topics: Animals; Ascorbic Acid; Atherosclerosis; Blood Glucose; Citrullus; Creatine Kinase, MB Form; Cucumis | 2008 |
Effects of long-term L-thyroxine treatment on endothelial function and arterial distensibility in young adults with congenital hypothyroidism.
Topics: Adolescent; Atherosclerosis; Brachial Artery; Case-Control Studies; Congenital Hypothyroidism; Endot | 2010 |
Thyroid function influences serum apolipoprotein B-48 levels in patients with thyroid disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Apolipoprotein B-48; Atherosclerosis; Case-Control Studi | 2012 |
Association between low serum free thyroxine concentrations and coronary artery calcification in healthy euthyroid subjects.
Topics: Adult; Aged; Atherosclerosis; Coronary Artery Disease; Cross-Sectional Studies; Female; Humans; Male | 2012 |
Low normal free T4 confers decreased high-density lipoprotein antioxidative functionality in the context of hyperglycaemia.
Topics: Aged; Antioxidants; Atherosclerosis; Blood Glucose; Body Mass Index; Cross-Sectional Studies; Diabet | 2013 |
ADMINISTRATION of hormones and related substances in atherosclerosis.
Topics: Arteriosclerosis; Atherosclerosis; Cholesterol; Estrogens; Hormones; Lipoproteins; Thyroxine | 1958 |
Effect of compounds related to thyroxine on serum and liver cholesterol and on atherosclerosis and heart weights in rats and mice.
Topics: Animals; Arteriosclerosis; Atherosclerosis; Cholesterol; Heart; Liver; Mice; Rats; Thyroxine | 1960 |
Some observations on the relationships between atherosclerosis, hyperlipemia, and D-thyroxine.
Topics: Arteriosclerosis; Atherosclerosis; Cholesterol; Dextrothyroxine; Estrogens; Humans; Hyperlipidemias; | 1962 |
Influence of dextro-thyroxine and androsterone on blood clotting factors and serum cholesterol in patients with atherosclerosis.
Topics: Androgens; Androsterone; Arteriosclerosis; Atherosclerosis; Blood Coagulation; Blood Coagulation Fac | 1961 |
[Action of dextro-thyroxine and androsterone on blood cholesterol and coagulation factors in atherosclerosis].
Topics: Androgens; Androsterone; Arteriosclerosis; Atherosclerosis; Blood Coagulation; Blood Coagulation Fac | 1961 |
[EFFECT OF DIFFERENT PHASES OF EXPERIMENTAL ATHEROSCLEROSIS, CORTISONE AND THYROXIN ON THE DEPOSITION OF 4-C14LABELLED CHOLESTEROL IN RABBIT AORTA].
Topics: Animals; Aorta; Arteriosclerosis; Atherosclerosis; Carbon Isotopes; Cholesterol; Cortisone; Lagomorp | 1963 |
[INFLUENCE OF SODIUM DEXTROTHYROXIN IN THE HORMONAL IMBALANCE OF ATHEROSCLEROSIS].
Topics: Arteriosclerosis; Atherosclerosis; Blood Proteins; Cholesterol; Dextrothyroxine; Lipid Metabolism; L | 1963 |
[THE PROBLEM OF TREATMENT OF ATHEROSCLEROSIS WITH THYROXIN OR RELATED COMPOUNDS].
Topics: Arteriosclerosis; Atherosclerosis; Humans; Thyroid Hormones; Thyroxine | 1963 |
[THE ACTION OF THYROMIMETIC COMPOUNDS ON EXPERIMENTAL ATHEROSCLEROSIS IN RABBITS AND ON CHOLESTEROL METABOLISM IN RATS].
Topics: Arteriosclerosis; Atherosclerosis; Cholesterol; Dinitrophenols; Lipid Metabolism; Lipoproteins; Phar | 1963 |
[ON CERTAIN BIOCHEMICAL ASPECTS OF THE DYSLIPEMIC PROCESS IN ITS RELATIONS TO ATHEROSCLEROSIS. TREATMENT TRIALS WITH D-THYROXIN].
Topics: Arteriosclerosis; Atherosclerosis; Cholesterol; Humans; Lipoproteins; Thyroxine | 1964 |
THYROIDAL INFLUENCE ON EXPERIMENTAL CHOLESTEROL ATHEROSCLEROSIS.
Topics: Adrenal Glands; Animals; Arteriosclerosis; Atherosclerosis; Blood Proteins; Body Weight; Cholesterol | 1964 |
[ACTION OF DEXTRO-THYROXIN IN TREATMENT OF DYSLIPEMIAS OF ATHEROSCLEROSIS].
Topics: Arteriosclerosis; Atherosclerosis; Dextrothyroxine; Humans; Lipidoses; Lipids; Thyroxine | 1964 |
Atherosclerosis and dextrorotatory thyroxine.
Topics: Arteriosclerosis; Atherosclerosis; Thyroxine | 1961 |
Effect of thyroxin and 2,4-dinitrophenol on the retrogression of experimental atherosclerosis.
Topics: 2,4-Dinitrophenol; Arteriosclerosis; Atherosclerosis; Dinitrophenols; Nitrophenols; Thyroxine | 1952 |
Osteopontin gene expression in the aorta and the heart of propylthiouracil-induced hypothyroid mice.
Topics: Animals; Aorta; Apolipoproteins E; Atherosclerosis; Blood Pressure; Blotting, Western; Body Weight; | 2005 |
Carotid artery intima media thickness is inversely related to serum free thyroxine in euthyroid subjects.
Topics: Adult; Aged; Aged, 80 and over; Atherosclerosis; Autoantibodies; C-Reactive Protein; Carotid Arterie | 2007 |